InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Kirby John J., Chief Financial Officer. Insider active across 2 companies, notably Idera Pharmaceuticals, INC.. Cumulatively, 6 reports have been published. Split: 3 buys · 0 sell. Total volume traded: €40k. History available since 17 December 2021. The latest transaction was disclosed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Kirby John J. is Chief Financial Officer and has been reported in 6 filings. Among the 6 sampled filings, the transactions are acquisitions, totaling EUR 39724, with filings dated from 2021-12-21 to 2026-08-18 at Verrica Pharmaceuticals Inc. and Idera Pharmaceuticals, INC.